Trofinetide
Generic name: Trofinetide
Brand names: Daybue
Dosage form: oral liquid (200 mg/mL)
Drug class:
Miscellaneous central nervous system agents
Usage of Trofinetide
Trofinetide is for use in adults and children at least 2 years old to treat Rett syndrome.
Trofinetide may also be used for purposes not listed in this medication guide.
Trofinetide side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Trofinetide may cause serious side effects. Call your doctor at once if you have:
Common side effects may include diarrhea or vomiting.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Trofinetide
Tell your doctor if you have or have ever had:
It is not known if trofinetide will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Ask a doctor if it is safe to breastfeed while using trofinetide.
Relate drugs
- Addyi
- Aducanumab
- Aducanumab-avwa
- Aduhelm
- Ampyra
- Bridion
- Dalfampridine
- Daybue
- Dextromethorphan and quinidine
- Droperidol
- Edaravone (Intravenous)
- Edaravone (Oral)
- Edaravone oral/injection
- Ergoloid mesylates
- Exservan
- Fezolinetant
- Flibanserin
- Hydergine
- Inapsine
- Lecanemab injection
- Lecanemab-irmb
- Leqembi
- Leqembi injection
- Memantine
- Namenda
- Namenda XR
- Namenda XR Titration Pack
- Nuedexta
- Omaveloxolone
- Qalsody
- Radicava
- Radicava ORS
- Relyvrio
- Rilutek
- Riluzole
- Skyclarys
- Sodium phenylbutyrate and taurursodiol
- Solriamfetol
- Sugammadex
- Sunosi
- Tiglutik
- Tofersen
- Trofinetide
- Veozah
How to use Trofinetide
Usual Adult Dose for Rett Syndrome:
Oral:18 years or older:-Weight 9 to less than 12 kg: 5,000 mg (25 mL) orally twice a day-Weight 12 to less than 20 kg: 6,000 mg (30 mL) orally twice a day-Weight 20 to less than 35 kg: 8,000 mg (40 mL) orally twice a day-Weight 35 to less than 50 kg: 10,000 mg (50 mL) orally twice a day-50 kg or more: 12,000 mg (60 mL) orally twice a dayComments:-This drug can be taken with or without food twice daily, in the morning and evening.-If a dose is missed, an additional dose should not be taken to make up for the missed dose. Instead, wait and continue with the next scheduled dose.-In the event of vomiting, do not take another dose to make up for that dose. Wait and take the following dose as scheduled.Use: For the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older
Usual Pediatric Dose for Rett Syndrome:
Oral:2 to less than 18 years:-Weight 9 to less than 12 kg: 5,000 mg (25 mL) orally twice a day-Weight 12 to less than 20 kg: 6,000 mg (30 mL) orally twice a day-Weight 20 to less than 35 kg: 8,000 mg (40 mL) orally twice a day-Weight 35 to less than 50 kg: 10,000 mg (50 mL) orally twice a day-50 kg or more: 12,000 mg (60 mL) orally twice a dayComments:-This drug can be taken with or without food twice daily, in the morning and evening.-If a dose is missed, an additional dose should not be taken to make up the missed dose. Instead, wait and continue with the next scheduled dose.-In the event of vomiting, do not take another dose to make up for that dose. Wait and take the following dose as scheduled.Use: For the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older
Warnings
Use only as directed. Tell your doctor if you use other medicines or have other medical conditions or allergies.
What other drugs will affect Trofinetide
Other drugs may affect trofinetide, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions